Hans-Joachim Huber

Title: The Innovations of Hans-Joachim Huber

Introduction

Hans-Joachim Huber is a notable inventor based in Munich, Germany. He has made significant contributions to the field of transdermal therapeutic systems. With a total of 3 patents to his name, Huber's work focuses on innovative methods for drug delivery through the skin.

Latest Patents

One of Huber's latest patents is a transdermal therapeutic system that utilizes physostigmine as an active component. This invention involves a system designed for the administration of physostigmine to the skin via a backing layer that is impermeable to active substances. The system includes an active substance deposit that comprises at least one auxiliary agent with supporting and distributing functions, surrounded by a matrix made of polymeric materials. Another patent by Huber also relates to a transdermal therapeutic system for physostigmine, featuring a pressure-sensitive adhesive reservoir layer and a removable protective layer. This innovative approach aims to enhance the effectiveness of drug delivery through the skin.

Career Highlights

Throughout his career, Hans-Joachim Huber has worked with reputable companies such as Klinge Pharma GmbH and LTS Lohmann Therapie-Systeme GmbH & Co. KG. His experience in these organizations has contributed to his expertise in developing advanced therapeutic systems.

Collaborations

Huber has collaborated with notable professionals in his field, including Gerhard Schneider and Fritz Stanislaus. These collaborations have likely enriched his work and led to further innovations in transdermal systems.

Conclusion

Hans-Joachim Huber's contributions to the field of transdermal therapeutic systems demonstrate his commitment to innovation and improving drug delivery methods. His patents reflect a deep understanding of pharmaceutical technology and a dedication to enhancing patient care.